These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 17696581)

  • 41. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T; Hayashi N; Ohira D; Torigoe H; Ito T; Hirose M; Sasaki Y; Shiga M; Miyazaki J; Kondo R; Tachikawa S
    J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies.
    Koehler D; Pavia D; Dewberry H; Hodder R
    Respiration; 2004; 71(5):469-76. PubMed ID: 15467324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients.
    Mann RD; Kubota K; Pearce G; Wilton L
    J Clin Epidemiol; 1996 Feb; 49(2):247-50. PubMed ID: 8606326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease.
    Fenton C; Keating GM
    Drugs; 2004; 64(17):1975-96. PubMed ID: 15329047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter.
    Given J; Taveras H; Iverson H; Lepore M
    Allergy Asthma Proc; 2013; 34(1):42-51. PubMed ID: 23265285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC; Martin P; Mezzanotte WS
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.
    Boshier A; Wilton LV; Shakir SA
    Eur J Clin Pharmacol; 2003 Dec; 59(10):767-73. PubMed ID: 14615857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
    Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.